TERVEST
Holdings
own accounts to 30-06-2025This companyTERVEST3 holdings, 1 country
accounts to 30-06-2025
Belgium 3 Year Equity Result
- BE 2026€479,957 result €19,128 (2026)
- BE 2026€377,413 result €36,234 (2026)
- BE 2025€204,464 result €61,918 (2025)
Source: list of holdings in its own 30-06-2025 accounts. Every holding stands with its own latest accounts.
At the same address
Sterrebeeklaan 32, 3080 Tervuren · 2 other companies| KRITO PHARMA
registered office since 07-11-2012 · founded in 2012 |
1 FTE (2026) 0500.718.255 |
| APOTHEEK HAEMELS
registered office since 17-03-2006 · founded in 2006 |
total assets €541,379 (2025) 0880.313.206 |
Holdings and subsidiaries
3 holdings · 4 subsidiaries, including indirect onesHoldings 3
Share, source and own figures per holding (3)
Source for every holding own accounts 30-06-2025
- subsidiaryEquity €204,464 Profit of €61,918 in 2025 (profit of €64,853 in 2024) Checked score100%
- subsidiaryEquity €479,957 Profit of €19,128 in 2026 (profit of €64,445 in 2025) Checked score100%
- subsidiaryEquity €377,413 Profit of €36,234 in 2026 (profit of €79,606 in 2025) Checked score100%
All subsidiaries, including indirect ones 4
TERVEST or one of its subsidiaries holds more than half of the shares of these companies. A company it consolidates per the LEI register is listed too.
- 100%
- 100%
100%1 subsidiary
- 100%
Board mandates elsewhere
1 board mandateBoard mandates of TERVESTTERVEST sits on their board1
Manager
Founded in 2003 · 3 FTE (2026)
Connections & network
4 current directorsThe board mandates are listed under Board mandates elsewhere. The network lets you explore the same ties.
This company
Company
Director
Shareholding
+N: links not shown yet
Bankruptcy, dissolution or liquidation
Click a node to look further, drag to arrange, zoom with the mouse wheel.